JP2024541257A5 - - Google Patents
Info
- Publication number
- JP2024541257A5 JP2024541257A5 JP2024525577A JP2024525577A JP2024541257A5 JP 2024541257 A5 JP2024541257 A5 JP 2024541257A5 JP 2024525577 A JP2024525577 A JP 2024525577A JP 2024525577 A JP2024525577 A JP 2024525577A JP 2024541257 A5 JP2024541257 A5 JP 2024541257A5
- Authority
- JP
- Japan
- Prior art keywords
- immune thrombocytopenia
- pharmaceutically acceptable
- acceptable salt
- compound
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111340688.4 | 2021-11-12 | ||
| CN202111340688 | 2021-11-12 | ||
| PCT/CN2022/131278 WO2023083281A1 (zh) | 2021-11-12 | 2022-11-11 | 一种喹啉酮衍生物治疗免疫性血小板减少症的用途 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024541257A JP2024541257A (ja) | 2024-11-08 |
| JP2024541257A5 true JP2024541257A5 (https=) | 2026-01-15 |
Family
ID=86335130
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024525577A Pending JP2024541257A (ja) | 2021-11-12 | 2022-11-11 | キノリノン誘導体の免疫性血小板減少症を治療するための使用 |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP4431097A4 (https=) |
| JP (1) | JP2024541257A (https=) |
| KR (1) | KR20240108437A (https=) |
| CN (1) | CN118159269A (https=) |
| AU (1) | AU2022386485A1 (https=) |
| CA (1) | CA3236272A1 (https=) |
| MX (1) | MX2024005200A (https=) |
| WO (1) | WO2023083281A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118436647A (zh) * | 2024-04-17 | 2024-08-06 | 湛江中心人民医院 | 沙利度胺的新应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012044936A1 (en) * | 2010-09-30 | 2012-04-05 | Portola Pharmaceuticals, Inc. | Combination therapy with 4-(3-(2h-1,2,3-triazol-2-yl)phenylamino)-2-((1r,2s)-2-aminocyclohexylamino)pyrimidine-5-carboxamide |
| TW201822764A (zh) * | 2016-09-14 | 2018-07-01 | 美商基利科學股份有限公司 | Syk抑制劑 |
| AU2018286247B2 (en) | 2017-06-14 | 2021-12-23 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Syk inhibitor and use method therefor |
| WO2020119785A1 (zh) * | 2018-12-14 | 2020-06-18 | 正大天晴药业集团股份有限公司 | 一种Syk抑制剂的盐及其结晶型 |
-
2022
- 2022-11-11 JP JP2024525577A patent/JP2024541257A/ja active Pending
- 2022-11-11 MX MX2024005200A patent/MX2024005200A/es unknown
- 2022-11-11 WO PCT/CN2022/131278 patent/WO2023083281A1/zh not_active Ceased
- 2022-11-11 CN CN202280074041.8A patent/CN118159269A/zh active Pending
- 2022-11-11 KR KR1020247018644A patent/KR20240108437A/ko active Pending
- 2022-11-11 AU AU2022386485A patent/AU2022386485A1/en active Pending
- 2022-11-11 CA CA3236272A patent/CA3236272A1/en active Pending
- 2022-11-11 EP EP22892074.0A patent/EP4431097A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2012321110B2 (en) | Combination treatment | |
| CN107872975A (zh) | 用于治疗恶心和呕吐的氨磺必利和其它止吐药的组合 | |
| JP2023535744A5 (https=) | ||
| JP2022514194A5 (https=) | ||
| JP2022550919A5 (https=) | ||
| KR20190016952A (ko) | 스테로이드 용량의 감소 및 염증과 자가면역 질환의 치료를 위한 칸나비디올 | |
| JP2024541257A5 (https=) | ||
| JP2024531314A5 (https=) | ||
| JP2024540044A5 (https=) | ||
| JP2024543509A5 (https=) | ||
| RU2749857C1 (ru) | Способ борьбы со средним и наружным отитом | |
| RU2024114849A (ru) | Применение производного хинолинона в лечении иммунной тромбоцитопении | |
| WO2023083281A1 (zh) | 一种喹啉酮衍生物治疗免疫性血小板减少症的用途 | |
| WO2020183020A1 (en) | Capsid assembly modulator solid formulation | |
| JP2022538898A5 (https=) | ||
| US20100184732A1 (en) | Method of long-term treatment of graft-versus-host disease using topical active corticosteroids | |
| AU2011202639A1 (en) | Compositions and methods for treating myelodysplastic syndrome | |
| WO2025208442A1 (en) | Methods of treatment of immune thrombocytopenia using sovleplenib | |
| EP2392329B1 (en) | Compositions for use in treating myelodysplastic syndrome | |
| JP2025511403A5 (https=) | ||
| CN107519176A (zh) | 防治运动病、梅尼埃病的药物及莫扎伐普坦的医药用途 | |
| JP7653712B2 (ja) | 高リスク骨髄異形成症候群の治療薬 | |
| TW202120092A (zh) | 化合物用於預防或治療移植物抗宿主病的用途 | |
| CN108478581A (zh) | 防治运动病、梅尼埃病的药物及托伐普坦的医药用途 | |
| US11957701B2 (en) | Therapy and new therapeutic agent for blood cancer |